Home Sleep Screening Devices Market Size & Share 2025 - 2034

Home Sleep Screening Devices Market Size

The global home sleep screening devices market size was valued at USD 3.4 billion in 2024. The market is expected to reach from USD 3.5 billion in 2025 to USD 6.7 billion in 2034, growing at a CAGR of 7.3% during the forecast period. The high market growth can be attributed to the advancement in technology within portable and wearable devices, the increasing need for efficient and inexpensive options, escalating awareness and diagnosis rates, and heightened elderly population are some of the factors contributing to the enormous growth.

Additionally, the growing number of people with sleep disorders like obstructive sleep apnea, insomnia, and restless leg syndrome is propelling the market. For example, the American Sleep Association made projections in 2023 that around 50 to 70 million people in America have some form of sleep disorder, with insomnia affecting roughly 30% of them.
 

Similarly, according to the CDC, around 25 million Americans were suffering from obstructive sleep apnea in 2022. The expanding awareness of the threats resulting from unattended sleep disorders is increasing the amount of people seeking solutions, in particular, home sleep screening devices.
 

In addition, the advancement of portable devices made it possible to develop compact, easy to use, and accurate home sleep screening devices. Users and healthcare professionals can benefit from enhanced user experience through wireless connections, cloud data storage, and smartphone integration.
 

Home sleep screening devices are medical equipment that helps in the measuring and monitoring of sleeping patterns and disorders including obstructive sleep apnea (OSA), insomnia, and restless leg syndrome (RLS). These devices are in the form of wearable technologies like smartwatches and fitness trackers as well as in the form of non-wearable systems that include portable polysomnography and sleep apnea monitors.
 

Home Sleep Screening Devices Market Trends

The market is rapidly evolving owing to continuous advancements in sensor technology, growing adoption of wearable devices, growth in remote patient monitoring (RPM) technologies, the widespread use of telehealth, and the increasing need for artificial intelligence in healthcare and machine learning, and many other aspects are propelling the growth of the market.
 

• Further, the surge in adoption of RPM systems is creating additional demand for home sleep screening devices capable of real-time data transmission to the relevant healthcare providers. In 2023, more than 2.4 million patients were reported to have utilized remote RPM services, and the Centers for Medicare & Medicaid Services (CMS) reported a 171% increase in claims from 2021 to 2022.
   
• In 2023, the American Medical Association reported that 30% of healthcare providers utilized peripheral devices for the remote monitoring of sleep disorders as opposed to 12% in 2021. These devices allow for the remote diagnosis and management of sleep disorders without the need for face to face consultations, which makes it more convenient for the patients.
   
• In addition, sleep monitoring enabled wearable devices, especially smartwatches and fitness trackers, have become very common in recent years. In addition to helping with daily activities, these devices facilitate sleep surveillance as they monitor various sleep parameters automatically.
   
• Further, manufacturers are working on the design of sleep monitoring devices that are comfortable and easy to use. There is a growing scope for the lightweight, non-intrusive, and easy-to-use designs as clients want practical and effective devices for sleep studies which helps in expansion of the market.
   
• As per the FDA the approved devices for sleep monitoring increased by 32% from 2021 to 2023. The U.S. Centers for Medicare & Medicaid Services showed that the reimbursement claims for home sleep testing devices increased by 45% from 2021 to 2024, which shows greater acceptance among the patients for easier monitoring devices.
   

Impact of Tariff on the Market

• The imposition of tariffs on the importation of medical devices, particularly home sleep screening devices, will negatively impact the home sleep screening devices market. This is because the sensors, microelectronics, and medical-grade plastics which are key components of the devices, have to be sourced from China and Mexico, and these tariffs will increase their prices. As a result, manufacturers will incur high production costs which will raise the retail prices of essential goods, in this case home sleep testing devices.
   
• Healthcare providers like DMEs face the brunt of the costs in a non-negotiable reimbursement framework with Medicare and private payers. Providers who are unwilling or unable to bear the costs will restrict access to home sleep screening devices, which makes the critical tools less accessible for patients who need them.
   
• Then again, these tariffs will also cause issues with the global supply chain, which hinders the timely delivery of the needed components and end products. This will make the devices less accessible to the patients and healthcare professionals who need them to accurately and expediently identify and manage sleep disorders.
   
• In addressing these issues, some industry associations may lobby for the exclusion of medical devices from tariffs, along with suggested policies that will focus on bolstered domestic manufacturing aimed to build the healthcare supply chain. Although, the border gaps which need to be filled with new manufacturing facilities in the country have persistent issues of expensive spending and long periods of time.
   
• As a consequence, tariffs imposed on the home sleep screening device market will create new cost and operational problems which may complicate accessibility of these medical devices for patients.
   

Home Sleep Screening Devices Market Analysis

Based on product type, the market is classified into wearable devices and non-wearable devices. The wearable devices segment is further bifurcated into smartwatches, fitness trackers, and other wearable devices. The wearable devices segment dominated the market in 2024 and was valued at USD 2 billion growing from USD 1.7 billion in 2021.
 

• Wearable technologies offer a unique method of monitoring sleep and include smart watches, fitness trackers, and sleep monitors. Since these devices are lightweight, patients can unobtrusively use them throughout the night. These devices are versatile for any individual looking to effortlessly track their sleep cycles.
   
• The International Data Corporation (IDC) put out a statement saying that global shipments of wearable technology reached USD 534.3 million in 2022, out of which, smartwatches and fitness trackers made up 38.4% of the share. In addition, a 47% increase in approvals for wearable sleep monitoring devices reported by U.S. FDA from 2021 to 2023 certainly shows an increase of consumers to these devices.
   
• Moreover, greater focus on the importance of sleep health and its impacts on general well-being is increasing the popularity of sleep tracking devices. As reported by the CDC in 2023, around 32.3% of adults in America reported sleep deprivation, which is an increase from 28.7% in 2021.
   
• In addition, the National Institutes of Health conducted a survey in 2023 and reported a 47% increase in the use of sleep tracking devices from 2021. Currently, 38% of adults use these devices to track their sleep and tackle sleep-related problems, which is driving the market.
   

Based on application, the home sleep screening devices market is classified into obstructive sleep apnea (OSA), insomnia, restless leg syndrome, circadian rhythm disorders, and other applications. The obstructive sleep apnea (OSA) segment accounted for USD 1.6 billion in market revenue in 2024 and is anticipated to grow at a CAGR of 7.7% between the 2025 to 2034 period.
 

• Obstructive Sleep Apnea(OSA) is one of the common sleep disorders. The AMA estimates that 936 million adults aged 30 to 69 are suffering from OSA globally. The growing awareness regarding associated health risks such as greater chances of cardiovascular troubles, diabetes, and sleepiness during the day fuels the need for early diagnosis and treatment.
   
• The 2022 CDC reports that out of American adults, 28% suffers from sleep deprivation, which has led to an increase in OSA checks. The NHS UK has reported that the referrals for sleep disorders surged from 2021 to 2023 by 213% adding to the demand for home sleep tests.
   
• Further, public health campaigns and programs are intended to increase knowledge of OSA symptoms and the dangers of not treating them. For instance, the CDC had a report of a 45% increase in OSA education programs between 2021 and 2023.
   
• In the same way, the NIH also recorded a 32% rise in sleep apnea diagnoses in 2022 compared to 2021, while the use of home sleep screening devices saw a 28% increase in 2023. These factors will likely accelerate the expansion of this particular market segment.
   

Learn more about the key segments shaping this market

Download Free PDF

Based on distribution channel, the home sleep screening devices market is segmented into brick & mortar and e-commerce. The brick & mortar segment dominated the market in 2024 and is anticipated to reach USD 4.6 billion by the end of the forecast period.
 

• Pharmacies, medical supply stores, and sleep clinics serve as physical retail outlets from where consumers are able to comfortably purchase health-related goods. In 2023, the National Retail Federation (NRF) reported that more than 72% of consumers purchase health goods in-store. These locations have knowledgeable staff who offer product advice, fostering customer trust and boosting sales.
   
• According to the U.S. Bureau of Labor and Statistics, employment in health and personal care stores increased by 3.2% in 2022, indicating a greater need for purchasing healthcare products in store. In addition, a study by the Consumer Healthcare Products Association in 2023 found that 65% of consumers use the services of a pharmacist for self-medication products.
   
• In addition, physical stores provides a hands-on experience which is lacking in online shopping. Consumers are able to examine home sleep screening devices, have their queries responded, and receive tailored advice from salespeople, which leads to a higher level of customer satisfaction. This should lead to greater demand on this portion of the market and therefore greater growth of the segment.
   

U.S. home sleep screening devices market generated USD 1.2 billion in revenue in 2024, reflecting growth from USD 1.1 billion in 2023 and USD 1 billion in 2021. The market is projected to expand at a CAGR of 6.4% from 2025 to 2034.
 

• Unlike conventional polysomnography tests that must be done in lab settings, home sleep screening devices are much more affordable and cost effective for both patients and caregivers. In 2023, the home sleep test is projected to cost between USD 150 to USD 500, whereas the in lab polysomnography could set a patient back by USD 1,000 to USD 3,500 according to the Center for Medicare and Medicaid Services.
   
• As many providers turn towards home sleep tests, insurance coverage is anticipated to increase, with predicted rates going from 75% in 2021 up to 85% in 2023. The American Academy of Sleep Medicine noted in 2022 that the lower price of home sleep based tests is enticing to American consumers, especially due to the rise in healthcare expenditure per capita by 4.1% in 2022 and 3.8% in 2023.
   
• In addition, the expanding focus on preventive care in the U.S. will boost the demand for sleeping screening devices. Self-monitoring made easier with accessible sleep health tools, such as home sleep tests, has the potential to identify signs of sleep disorders and other underlying issues much earlier, thus averting more serious health complications in the future which will further expand the market.
   

Germany home sleep screening devices market in the Europe is projected to grow remarkably in the coming years.
 

• The German healthcare system has an inclusive backing for diagnostic technologies. This includes peripheral medical equipment such as home sleep screening devices. The pre-existing reimbursement policy regarding medical devices makes it easier for patients to undergo home sleep testing. In 2021, Germany's healthcare expenditure was USD 496.2 billion and the reimbursements for medical devices was around USD 34.9 billion according to German Federal Statistical Office.
   
• The German Sleep Society claimed that more than 65% of sleep studies in 2022 were done through home sleep testing devices which is a 15% increase from 2021. With an increase in use of home sleep testing devices, the G-BA managed the coverage expansion for sleep testing devices in 2023, resulting in the adoption of 22% more testing devices. This set of regulations also encourages both doctors and patients to take advantage of home sleep screening options.
   
• In addition, there has been a greater adoption of telemedicine in recent years within the country which has contributed to greater use of home-based diagnostic sleep devices. Healthcare professionals are able to remotely monitor and consult patients and analyze sleep data received from home sleep screening devices enhancing remote management of patients sleep health.
   

Japan holds a dominant position in the Asia Pacific home sleep screening devices market.
 

• With one of the world’s oldest populations, Japan is at risk of having a considerable share of elderly people suffering from sleep disorders, especially obstructive sleep apnea (OSA). The Ministry of Internal Affairs and Communications estimated this rate will increase to 30% by 2024.
   
• The National Center of Neurology and Psychiatry also estimated that in 2022 about three million Japanese adults had sleep apnea, out of which 40% of the cases were recorded from individuals aged over 65. Home sleep screening devices are more attractive to elderly patients who cannot or prefer not to go for in-lab sleep studies, thus increasing the need for remote testing and home diagnostic devices.
   
• In addition, the Japanese workforce is also dealing with great stress coupled with long hours of work. As per Japan's Ministry of Health, Labor, and Welfare, the percentage of employees suffering from work-related stress increased from 40% in the year 2013 to 52.7% in 2023. Furthermore, the portion of employees working more than 49 hours a week was recorded at 27.8% in 2022.
   
• According to a government survey conducted in 2023, 48.3% of adult Japanese report getting less than six hours of sleep each night. Concern on health and productivity has increased in regard to workplace sleep and has driven the adoption of their home Sleep Monitoring devices. For Japan, the sleep technology market reached the value of almost USD 1 billion in 2023.
   

Brazil holds a dominant position in the Latin America home sleep screening devices market.
 

• Brazil is experiencing an upsurge in sleep disorders, particularly obstructive sleep apnea (OSA). Surgeons attribute this increase to the prevailing rates of obesity, the aging population, and increased awareness of sleep health. This, in turn, creates a greater need for readily available and easy-to-use diagnostic tools, such as home sleep screening devices.
   
• Moreover, the development of novel sleep-monitoring technologies has increased the accuracy of home sleep tests, including wearable devices, smartphone apps, and portable polysomnography. The ability to perform real-time analysis of the gathered data increases the adequateness of these devices and their appeal to the patients.
   
• In addition, a prominent driver of health care expenditures in Brazil is the shift towards more patient-centered and cost-efficient care models. This has led to a greater demand for Home Sleep Screening Devices, which allow patients to conduct sleep tests from the comfort of their own residences, minimizing reliance on healthcare facilities.
   

Home Sleep Screening Devices Market Share

The market is fragmented in nature, with key players providing novel products and services. Top players, such as ResMed and Philips, which provide innovative solutions. These companies, along with SomnoMed, control roughly 35% of the global market with their clinically validated home sleep test devices. Moreover, Withings and Fitbit are newer competitors who leverage wearable technology and AI to provide low-cost, easy solutions. SomnoMed and Philips are also working with other healthcare providers to use their devices for remote telemedicine and monitoring services. The market has high competitiveness due to the continuous improvement in diagnostic accuracy and the introduction of new technologies.
 

Home Sleep Screening Devices Market Companies

Prominent players operating in the home sleep screening devices industry include:

• ApneaMed
• BMC
• BRAEBON
• CleveMed
• GARMIN
• HUAWEI
• natus
• NovaSom
• PHILIPS
• ResMed
• SleepWorks
• SOMNOmedics
• VIRTUOX
• ZEPP
• ZOLL itamar
   
• ResMed is a global leader in sleep and respiratory care, providing clinically approved at-home sleep apnea tests as well as cloud-connected CPAP devices that can easily be integrated with remote monitoring digital health platforms.
   
• Philips, best-known for its accurate, simple to use, AI-powered sleep analysis, also provides an array of sleep diagnostics solutions such as in-home sleep testing devices, as well as CPAP therapy devices.
   
• SOMNOmedics focuses on portable, high resolution sleep diagnostic systems and provide compact, wireless PSG and actigraphy systems capable of real-time data analysis for home and clinical use.
   

Home Sleep Screening Devices Industry News

• In August 2024, ReactDx has launched NiteWatch, an FDA cleared home sleep screening device which measures six health parameters and has verification against polysomnography. This launch increases company’s market share by offering a low cost diagnostic tool that meets the growing demand for dependable home testing devices.
   
• In January 2023, Bresotec Medical obtained a 510(k) from the U.S. FDA for BresoDX1, it’s at-home sleep apnea testing device. The FDA accepted BresoDX1 as a home diagnostic tool for moderate to severe sleep apnea in adults. This approval boosts company’s market standing and allows the company to meet the growth in need for testing devices in the domiciliary setting.
   
• In February 2024, Vivos Therapeutics launched VivoScore, a home sleep device powered by SleepImage. It consists of a single-sensor ring recorder that interfaces with a mobile app and cloud based algorithms to monitor sleep and diagnose sleep apnea. This change increases company’s product portfolio and provides a cost effective and convenient sleep screening solution to patients and healthcare professionals.
   

The home sleep screening devices market research report includes in-depth coverage of the industry with estimates and forecasts in terms of revenue in USD Million from 2021 – 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Product Type

• Wearable devices
  • Smartwatches
  • Fitness trackers
  • Other wearable devices
• Non-wearable devices

Market, By Application

• Obstructive sleep apnea (OSA)
• Insomnia
• Restless leg syndrome
• Circadian rhythm disorders
• Other applications

Market, By Distribution Channel

• Brick & mortar
• E-commerce

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE